RAG2 KO and MDR1A/RAG2 dKO mice were subjected to the AOM/DSS protocol and followed up to week 20, as initial results suggested delayed overall tumor development in both RAG2-deficient mice strains (data not shown). This evidence concerns the gene RAG2 and neoplasm.